DOXYCYCLINE HYCLATE

Generic: DOXYCYCLINE HYCLATE

Chartwell RXManufacturer
ORALRoute
DOXYCYCLINE HYCLATEActive Substance
2014-07-25Original Approval

DOXYCYCLINE HYCLATE is FDA application NDA205931, sponsored by CHARTWELL RX. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Class II2020-05-13
Doxycycline Hyclate Tablets USP, 100 mg, packaged in a) 50-count bottle (NDC 0143-2112-50), b) 500-count bottle (NDC 014

Failed dissolution specification: The dissolution test at the 24 month time point (end of shelf life

Class II2022-04-13
Doxycycline Hyclate Tablets, USP, 100 mg, 50-count carton (10 tablets each blister pack x 5), Rx only, MFG: Major Pharma

cGMP deviations: Temperature abuse

Class II2018-07-24
Doxycycline Hyclate Tablets, USP, 100 mg*. 500-count bottle, Rx only. Manufactured by: West-Ward Pharmaceuticals Corp. E

Failed Dissolution Specifications:

Class II2018-07-24
Doxycycline Hyclate Tablets, USP, 100 mg*. 50-count bottle, Rx only. Manufactured by: West-Ward Pharmaceuticals Corp. Ea

Failed Dissolution Specifications:

Class II2018-08-01
Doxycycline Hyclate Tablets, USP, 100 mg, 30 Tablets per carton (3 x 10 Unit Dose Blisters), Rx Only, Distributed by: A

Failed Dissolution Specifications: Out of specification result for the dissolution test.

Class II2018-07-30
Doxycycline Hyclate Tablets, USP, 100 mg, Rx Only, 30 tablets, 3 x 10 unit dose Cartons, Mfd. by: West-Ward Pharmaceutic

Failed Dissolution Specifications

Class II2020-05-22
Doxycycline Hyclate Tablets, USP, 100 mg, packaged in a) 3x10 unit dose cartons (NDC 0904-0430-04) and b) 5 x 10 unit do

Failed Dissolution Specification: The dissolution test at the 24 month time point (end of shelf life

Class II2020-05-19
Doxycycline Hyclate Tablets, USP, 100 mg, 30 Tablets per carton (3 x 10), Rx only, Distributed by: American Health Packa

Failed dissolution specification - dissolution results of 59% (spec. NLT 85%) at the 24 month time p

Top Reported Reactions

1
DRUG INEFFECTIVE
5,411 reports
2
NAUSEA
5,093 reports
3
OFF LABEL USE
4,917 reports
4
FATIGUE
4,807 reports
5
RASH
4,249 reports
6
DYSPNOEA
4,136 reports
7
DIARRHOEA
4,126 reports
8
PAIN
4,071 reports
9
HEADACHE
3,986 reports
10
VOMITING
3,914 reports